Opportunity Information: Apply for 7200AA24RFA00009
The Global Resilience Against Drug-Resistant Tuberculosis (GRAD-TB) opportunity is a USAID Notice of Funding Opportunity (NOFO) seeking applications for a single cooperative agreement to run a global program focused on drug-resistant tuberculosis (DR-TB). The solicitation is identified as Funding Opportunity Number 7200AA24RFA00009 under CFDA/Assistance Listing 98.001, and it sits in the health funding category. Because it is a cooperative agreement, applicants should expect substantial involvement from USAID during implementation, such as collaboration on technical direction, planning, monitoring, and adaptation as the work progresses.
The core purpose of GRAD-TB is to help USAID-supported tuberculosis countries strengthen how they detect, treat, and prevent DR-TB, with an emphasis on faster identification of resistant disease, improved treatment outcomes, and stronger prevention approaches. The program is meant to do this in two main ways: first, by developing and putting into practice innovative approaches and best practices that can accelerate progress against DR-TB, and second, by providing specialized technical assistance to local partners and National TB Programs. In practical terms, this points to a program that not only introduces new methods and tools, but also helps country programs and local implementers build the skills, systems, and operational capacity needed to use those methods effectively and at scale.
A major framing element of the opportunity is alignment with global and U.S. strategy commitments. GRAD-TB is designed to support countries in meeting the commitments they made at the 2023 United Nations High-Level Meeting (UNHLM) on TB, while staying consistent with the World Health Organization End TB Strategy and USAID's Global TB Strategy 2023-2030. This means applicants will likely need to show how their proposed work will translate high-level targets into measurable country-level improvements, and how they will track progress in a way that is credible to both national stakeholders and global reporting expectations.
The expected results are centered on lowering the burden of DR-TB by improving rapid detection, strengthening treatment, and advancing prevention, while also building systems that last. The announcement emphasizes sustainability and resilience through the use of local organizations and locally driven approaches, suggesting a strong preference for capacity strengthening, local leadership, and implementation models that can continue beyond the life of the award. It also explicitly highlights that approaches should be equitable, inclusive, and accessible, pointing to attention to who is reached by services, which groups are missed, and how barriers to care are reduced in real-world settings.
Eligibility is unrestricted, meaning the competition is open to any eligible and qualified applicants, including U.S.-based, local, and international non-governmental entities. USAID anticipates making one award, with an award ceiling of up to $90,000,000. The original closing date listed for applications is May 31, 2024, and the full instructions, requirements, and submission details are contained in the complete announcement package available in the "Related Documents" section referenced in the notice.Apply for 7200AA24RFA00009
- The Agency for International Development in the health sector is offering a public funding opportunity titled "Global Resilience Against Drug-Resistant Tuberculosis (GRAD-TB)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001.
- This funding opportunity was created on 2024-04-19.
- Applicants must submit their applications by 2024-05-31. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $90,000,000.00 in funding.
- Eligible applicants include: Unrestricted.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same agency: Agency for International Development
Browse more opportunities from the same category: Health
Next opportunity: Strengthening Decent Work in the Fishing Sector in South America
Previous opportunity: Private Sector Collaboration Pathway (PSCP) Jordan Addendum
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for 7200AA24RFA00009
Applicants also applied for:
Applicants who have applied for this opportunity (7200AA24RFA00009) also looked into and applied for these:
| Funding Opportunity |
|---|
| Human Leukocyte Antigen (HLA) and Killer-cell Immunoglobulin-like Receptor (KIR) Region Genomics in Immune-Mediated Diseases (U01 Clinical Trial Not Allowed) Apply for RFA AI 24 017 Funding Number: RFA AI 24 017 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Safety and Early Efficacy Studies of Psychedelic-Assisted Therapy for Chronic Pain in Older Adults (UG3/UH3 Clinical Trial Required) Apply for RFA AG 25 004 Funding Number: RFA AG 25 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Engineering Durable HIV Vaccine Responses (ENDURE) (R01 Clinical Trial Not Allowed) Apply for RFA AI 24 025 Funding Number: RFA AI 24 025 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional) Apply for RFA HL 26 002 Funding Number: RFA HL 26 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional) Apply for RFA HL 26 003 Funding Number: RFA HL 26 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Comprehensive Alcohol Research Centers (P60 Clinical trial Optional) Apply for RFA AA 24 008 Funding Number: RFA AA 24 008 Agency: National Institutes of Health Category: Health Funding Amount: $1,250,000 |
| Ensuring Social Protection by Empowering and building Resiliency for Adolescents, Nuclear families, Children, and caregivers affected by HIV/AIDS (ESPERANÇA) Apply for RFI7206562024 Funding Number: RFI7206562024 Agency: Mozambique USAID-Maputo Category: Health Funding Amount: $40,000,000 |
| Specialized Alcohol Research Centers (P50 Clinical trial Optional) Apply for RFA AA 24 007 Funding Number: RFA AA 24 007 Agency: National Institutes of Health Category: Health Funding Amount: $1,150,000 |
| Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Not Allowed) Apply for RFA HL 25 009 Funding Number: RFA HL 25 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Required) Apply for RFA HL 25 008 Funding Number: RFA HL 25 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Request for Information for USAID/Namibia Key Populations - Resilience, Innovation, Sustainability, and Empowerment (KP-RISE) Apply for RFI 673 24 Funding Number: RFI 673 24 Agency: South Africa USAID-Pretoria Category: Health Funding Amount: Case Dependent |
| ML/AI Tools to Advance Genomic Translational Research (MAGen) - Coordinating Center (UG3/UH3, Clinical Trials Not Allowed) Apply for RFA HG 24 005 Funding Number: RFA HG 24 005 Agency: National Institutes of Health Category: Health Funding Amount: $800,000 |
| ML/AI Tools to Advance Genomic Translational Research (MAGen) - Development Sites (UG3/UH3 Clinical Trials Not Allowed) Apply for RFA HG 24 004 Funding Number: RFA HG 24 004 Agency: National Institutes of Health Category: Health Funding Amount: $1,600,000 |
| NINDS Research Education Opportunities (R25 Clinical Trial Not Allowed) Apply for PAR 24 200 Funding Number: PAR 24 200 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Access and Manipulation of Brain Cell Subtypes Implicated in Aging and AD/ADRD (R61/R33 Clinical Trial Not allowed) Apply for RFA AG 25 024 Funding Number: RFA AG 25 024 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NEI Research for Low Vision and Blindness Accessibility Tools (R61/R33 Clinical Trial Optional) Apply for RFA EY 24 003 Funding Number: RFA EY 24 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCR Dual Degree Dentist Scientist Predoctoral to Postdoctoral Transition Award (F99/K00 Independent Clinical Trial Not Allowed) Apply for PAR 25 021 Funding Number: PAR 25 021 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Safety and Efficacy of Amyloid-Beta Directed Antibody Therapy in Mild Cognitive Impairment and Dementia with Evidence of Lewy Body Dementia and Amyloid-Beta Pathology (U01 - Clinical Trial Required) Apply for RFA NS 25 010 Funding Number: RFA NS 25 010 Agency: National Institutes of Health Category: Health Funding Amount: $6,700,000 |
| Single Source: NINDS Exploratory Clinical Trials (U01 Clinical Trial Required) Apply for PAR 24 215 Funding Number: PAR 24 215 Agency: National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) Apply for PAR 24 208 Funding Number: PAR 24 208 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "7200AA24RFA00009", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.